485 related articles for article (PubMed ID: 2411398)
1. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
2. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Fox PA; Panasci LC; Schein PS
Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
[TBL] [Abstract][Full Text] [Related]
3. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
Ahlgren JD; Green DC; Tew KD; Schein PS
Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Schein PS; Bull JM; Doukas D; Hoth D
Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400
[TBL] [Abstract][Full Text] [Related]
5. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
6. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
Sariban E; Erickson LC; Kohn KW
Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
[TBL] [Abstract][Full Text] [Related]
7. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
[TBL] [Abstract][Full Text] [Related]
8. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
Bedford P; Eisenbrand G
Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
[TBL] [Abstract][Full Text] [Related]
9. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
[TBL] [Abstract][Full Text] [Related]
10. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Heal JM; Fox PA; Doukas D; Schein PS
Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
Nagourney RA; Fox P; Schein PS
Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
[TBL] [Abstract][Full Text] [Related]
12. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
Aoshima M; Sakurai Y
Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
[TBL] [Abstract][Full Text] [Related]
14. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
Brajtburg J; Elberg S; Schechtman KB; Medoff G
Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
[TBL] [Abstract][Full Text] [Related]
15. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
16. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
Tew KD; Wang AL
Mol Pharmacol; 1982 May; 21(3):729-38. PubMed ID: 7110120
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
Baril BB; Baril EF; Laszlo J; Wheeler GP
Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
19. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
20. Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice.
Schmalbach TK; Borch RF
Cancer Res; 1989 May; 49(10):2574-7. PubMed ID: 2540902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
